Altimmune (ALT) Earnings Date & Reports

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases... Show more

Industry: #Miscellaneous Commercial Services

Get AI intraday signals

A.I. Advisor

published Earnings

ALT is expected to report earnings to rise 15.46% to -30 cents per share on August 07

Q2'25

Est.

$-0.30

Q1'25

Beat

by $0.12

Q4'24

Beat

by $0.01

Q3'24

Beat

by $0.04

Q2'24

Est.

$-0.35

The last earnings report on May 13 showed earnings per share of -25 cents, beating the estimate of -37 cents. With 2.27M shares outstanding, the current market capitalization sits at 442.84M.

View a ticker or compare two or three

Compare

ALT